Class Action

Combivent Respimat Asthma Inhalers

Class Action

Combivent Respimat Asthma Inhalers

In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)


The Latest

Filters

TINA.org Reports Meal Kit Giant HelloFresh to FTC

Press Release

TINA.org Reports Meal Kit Giant HelloFresh to FTC

MADISON, CONN. June 22, 2022 While millions of Americans struggle with rising food prices and empty store shelves, meal kit retailer HelloFresh advertises “delicious meals delivered to your door,” enticing consumers…


Show More